BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goadsby P, Charbit A, Andreou A, Akerman S, Holland P. Neurobiology of migraine. Neuroscience 2009;161:327-41. [DOI: 10.1016/j.neuroscience.2009.03.019] [Cited by in Crossref: 260] [Cited by in F6Publishing: 230] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Digre KB, Brennan KC. Shedding light on photophobia. J Neuroophthalmol 2012;32:68-81. [PMID: 22330853 DOI: 10.1097/WNO.0b013e3182474548] [Cited by in Crossref: 137] [Cited by in F6Publishing: 60] [Article Influence: 13.7] [Reference Citation Analysis]
2 Dussor G, Yan J, Xie JY, Ossipov MH, Dodick DW, Porreca F. Targeting TRP channels for novel migraine therapeutics. ACS Chem Neurosci 2014;5:1085-96. [PMID: 25138211 DOI: 10.1021/cn500083e] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 6.5] [Reference Citation Analysis]
3 Bautista DM, Pellegrino M, Tsunozaki M. TRPA1: A gatekeeper for inflammation. Annu Rev Physiol 2013;75:181-200. [PMID: 23020579 DOI: 10.1146/annurev-physiol-030212-183811] [Cited by in Crossref: 241] [Cited by in F6Publishing: 228] [Article Influence: 24.1] [Reference Citation Analysis]
4 Schürks M, Rist PM, Kurth T. STin2 VNTR polymorphism in the serotonin transporter gene and migraine: pooled and meta-analyses. J Headache Pain 2010;11:317-26. [PMID: 20585826 DOI: 10.1007/s10194-010-0230-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
5 Posadzki P, Ernst E. Spinal manipulations for the treatment of migraine: A systematic review of randomized clinical trials. Cephalalgia 2011;31:964-70. [DOI: 10.1177/0333102411405226] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
6 Schytz HW, Hargreaves R, Ashina M. Challenges in developing drugs for primary headaches. Progress in Neurobiology 2017;152:70-88. [DOI: 10.1016/j.pneurobio.2015.12.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
7 Maleki N, Barmettler G, Moulton EA, Scrivani S, Veggeberg R, Spierings ELH, Burstein R, Becerra L, Borsook D. Female migraineurs show lack of insular thinning with age. Pain 2015;156:1232-9. [PMID: 25775358 DOI: 10.1097/j.pain.0000000000000159] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
8 Uluduz D, Ayta S, Özge A, Yalin OÖ, Temel GÖ, Taşdelen B; Turkish Headache Database Study Group. Cranial Autonomic Features in Migraine and Migrainous Features in Cluster Headache. Noro Psikiyatr Ars 2018;55:220-4. [PMID: 30224867 DOI: 10.5152/npa.2016.19183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
9 Song HS, Shin JS, Lee J, Lee YJ, Kim MR, Cho JH, Kim KW, Park Y, Song HJ, Park SY, Kim S, Kim M, Ha IH. Association between temporomandibular disorders, chronic diseases, and ophthalmologic and otolaryngologic disorders in Korean adults: A cross-sectional study. PLoS One 2018;13:e0191336. [PMID: 29385182 DOI: 10.1371/journal.pone.0191336] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
10 Eftekhari S, Gaspar RC, Roberts R, Chen TB, Zeng Z, Villarreal S, Edvinsson L, Salvatore CA. Localization of CGRP receptor components and receptor binding sites in rhesus monkey brainstem: A detailed study using in situ hybridization, immunofluorescence, and autoradiography. J Comp Neurol 2016;524:90-118. [PMID: 26105175 DOI: 10.1002/cne.23828] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
11 Gentile G, Negro A, D'Alonzo L, Aimati L, Simmaco M, Martelletti P, Borro M. Lack of association between oxidative stress-related gene polymorphisms and chronic migraine in an Italian population. Expert Rev Neurother 2015;15:215-25. [PMID: 25585507 DOI: 10.1586/14737175.2015.1001748] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
12 Palmirotta R, Barbanti P, Ialongo C, De Marchis ML, Alessandroni J, Egeo G, Aurilia C, Fofi L, Valente MG, Ferroni P, Della-Morte D, Guadagni F. Progesterone receptor gene (PROGINS) polymorphism correlates with late onset of migraine. DNA Cell Biol 2015;34:208-12. [PMID: 25494303 DOI: 10.1089/dna.2014.2534] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
13 Latif K, Khan AU, Izhar Ul Haque M, Naeem K. Bergapten Attenuates Nitroglycerin-Induced Migraine Headaches through Inhibition of Oxidative Stress and Inflammatory Mediators. ACS Chem Neurosci 2021;12:3303-13. [PMID: 34455773 DOI: 10.1021/acschemneuro.1c00146] [Reference Citation Analysis]
14 Arakaki X, Galbraith G, Pikov V, Fonteh AN, Harrington MG. Altered brainstem auditory evoked potentials in a rat central sensitization model are similar to those in migraine. Brain Res 2014;1563:110-21. [PMID: 24680742 DOI: 10.1016/j.brainres.2014.03.033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
15 Peck K, Johnson Y, Smitherman T. Migraine. Neuroepidemiology. Elsevier; 2016. pp. 283-93. [DOI: 10.1016/b978-0-12-802973-2.00016-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
16 De Simone R, Ranieri A, Sansone M, Marano E, Russo CV, Saccà F, Bonavita V. Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine. Neurol Sci 2019;40:59-70. [PMID: 30838545 DOI: 10.1007/s10072-019-03775-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
17 Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hindiyeh N, Charles AC, Goadsby PJ, Lipton RB, Silberstein SD, Gelfand AA, Chiacchierini RP, Dodick DW. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study). Cephalalgia 2018;38:1038-48. [PMID: 29504483 DOI: 10.1177/0333102418762525] [Cited by in Crossref: 72] [Cited by in F6Publishing: 54] [Article Influence: 18.0] [Reference Citation Analysis]
18 Akerman S, Simon B, Romero-reyes M. Vagus nerve stimulation suppresses acute noxious activation of trigeminocervical neurons in animal models of primary headache. Neurobiology of Disease 2017;102:96-104. [DOI: 10.1016/j.nbd.2017.03.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 8.6] [Reference Citation Analysis]
19 Garg P, Servoss SJ, Wu JC, Bajwa ZH, Selim MH, Dineen A, Kuntz RE, Cook EF, Mauri L. Lack of association between migraine headache and patent foramen ovale: results of a case-control study. Circulation. 2010;121:1406-1412. [PMID: 20231534 DOI: 10.1161/circulationaha.109.895110] [Cited by in Crossref: 74] [Cited by in F6Publishing: 19] [Article Influence: 6.2] [Reference Citation Analysis]
20 Panerai AE. Physiopathology of cephalic pain: where are we? Neurol Sci 2015;36 Suppl 1:13-6. [PMID: 26017504 DOI: 10.1007/s10072-015-2178-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Andreou AP, Holland PR, Lasalandra MP, Goadsby PJ. Modulation of nociceptive dural input to the trigeminocervical complex through GluK1 kainate receptors. Pain 2015;156:439-50. [PMID: 25679470 DOI: 10.1097/01.j.pain.0000460325.25762.c0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
22 Pressman A, Jacobson A, Eguilos R, Gelfand A, Huynh C, Hamilton L, Avins A, Bakshi N, Merikangas K. Prevalence of migraine in a diverse community--electronic methods for migraine ascertainment in a large integrated health plan. Cephalalgia 2016;36:325-34. [PMID: 26069243 DOI: 10.1177/0333102415590242] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
23 Goadsby PJ. Pathophysiology of migraine. Ann Indian Acad Neurol 2012;15:S15-22. [PMID: 23024559 DOI: 10.4103/0972-2327.99993] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 7.2] [Reference Citation Analysis]
24 Eftekhari S, Warfvinge K, Blixt FW, Edvinsson L. Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system. J Pain. 2013;14:1289-1303. [PMID: 23958278 DOI: 10.1016/j.jpain.2013.03.010] [Cited by in Crossref: 125] [Cited by in F6Publishing: 115] [Article Influence: 13.9] [Reference Citation Analysis]
25 Abad N, Rosenberg JT, Hike DC, Harrington MG, Grant SC. Dynamic sodium imaging at ultra-high field reveals progression in a preclinical migraine model. Pain 2018;159:2058-65. [PMID: 29905652 DOI: 10.1097/j.pain.0000000000001307] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
26 Andreou AP, Summ O, Charbit AR, Romero-Reyes M, Goadsby PJ. Animal models of headache: from bedside to bench and back to bedside. Expert Rev Neurother 2010;10:389-411. [PMID: 20187862 DOI: 10.1586/ern.10.16] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
27 Bigal ME, Lipton RB, Newman LC, Pierce MW, Silberstein SD. Sumatriptan Iontophoretic Transdermal System Reduces Treatment-Emergent Nausea and Is Effective in Patients With and Without Nausea at Baseline - Results From a Randomized Controlled Trial. Headache: The Journal of Head and Face Pain 2015;55:1124-32. [DOI: 10.1111/head.12606] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
28 Yan J, Dussor G. Ion channels and migraine. Headache 2014;54:619-39. [PMID: 24697223 DOI: 10.1111/head.12323] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
29 Mccomas AJ, Upton ARM. Cortical spreading depression in migraine-time to reconsider? Arq Neuro-Psiquiatr 2015;73:714-21. [DOI: 10.1590/0004-282x20150094] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
30 Gomez-mancilla B, Brand R, Jürgens TP, Göbel H, Sommer C, Straube A, Evers S, Sommer M, Campos V, Kalkman HO, Hariry S, Pezous N, Johns D, Diener H; for the BGG492 Study Group. Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks. Cephalalgia 2014;34:103-13. [DOI: 10.1177/0333102413499648] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
31 Terrier LM, Fontaine D. Intracranial nociception. Rev Neurol (Paris) 2021:S0035-3787(21)00623-8. [PMID: 34384629 DOI: 10.1016/j.neurol.2021.07.012] [Reference Citation Analysis]
32 Gooriah R, Ahmed F. OnabotulinumtoxinA for chronic migraine: a critical appraisal. Ther Clin Risk Manag 2015;11:1003-13. [PMID: 26170679 DOI: 10.2147/TCRM.S76964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
33 Daiutolo BV, Tyburski A, Clark SW, Elliott MB. Trigeminal Pain Molecules, Allodynia, and Photosensitivity Are Pharmacologically and Genetically Modulated in a Model of Traumatic Brain Injury. J Neurotrauma 2016;33:748-60. [PMID: 26472135 DOI: 10.1089/neu.2015.4087] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
34 Xie HY, Cui Y, Deng F, Feng JC. Connexin: a potential novel target for protecting the central nervous system? Neural Regen Res 2015;10:659-66. [PMID: 26170830 DOI: 10.4103/1673-5374.155444] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
35 Beidleman BA, Fulco CS, Cadarette BS, Cymerman A, Buller MJ, Salgado RM, Posch AM, Staab JE, Sils IV, Yurkevicius BR, Luippold AJ, Welles AP, Muza SR. Is normobaric hypoxia an effective treatment for sustaining previously acquired altitude acclimatization? J Appl Physiol (1985) 2017;123:1214-27. [PMID: 28705998 DOI: 10.1152/japplphysiol.00344.2017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
36 Sokolov AY, Lyubashina OA, Amelin AV, Panteleev SS. The role of noradrenalin in the pathogenesis of primary headaches. Neurochem J 2013;7:256-65. [DOI: 10.1134/s1819712413040090] [Cited by in Crossref: 6] [Article Influence: 0.7] [Reference Citation Analysis]
37 Andreou AP, Holland PR, Akerman S, Summ O, Fredrick J, Goadsby PJ. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain 2016;139:2002-14. [PMID: 27246325 DOI: 10.1093/brain/aww118] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 10.7] [Reference Citation Analysis]
38 Green AL, Gu P, De Felice M, Dodick D, Ossipov MH, Porreca F. Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache. Cephalalgia 2014;34:594-604. [PMID: 24335852 DOI: 10.1177/0333102413515344] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
39 Park J, Moon H, Akerman S, Holland PR, Lasalandra MP, Andreou AP, Ferrari MD, van den Maagdenberg AM, Goadsby PJ. Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: A Fos protein study. Neurobiology of Disease 2014;64:1-7. [DOI: 10.1016/j.nbd.2013.12.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
40 Abdellatif MK, Fouad MM. Effect of duration and severity of migraine on retinal nerve fiber layer, ganglion cell layer, and choroidal thickness. European Journal of Ophthalmology 2018;28:714-21. [DOI: 10.1177/1120672117750054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
41 Asghar MS, Hansen AE, Amin FM, van der Geest RJ, Koning Pv, Larsson HB, Olesen J, Ashina M. Evidence for a vascular factor in migraine. Ann Neurol. 2011;69:635-645. [PMID: 21416486 DOI: 10.1002/ana.22292] [Cited by in Crossref: 193] [Cited by in F6Publishing: 171] [Article Influence: 17.5] [Reference Citation Analysis]
42 Arcioni R, Palmisani S, Mercieri M, Vano V, Tigano S, Smith T, Fiore M, Al-kaisy A, Martelletti P. Cervical 10 kHz spinal cord stimulation in the management of chronic, medically refractory migraine: A prospective, open-label, exploratory study. Eur J Pain 2016;20:70-8. [DOI: 10.1002/ejp.692] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
43 Zagami AS, Shaikh S, Mahns D, Lambert GA. A potential role for two brainstem nuclei in craniovascular nociception and the triggering of migraine headache. Cephalalgia 2021;41:203-16. [PMID: 32990035 DOI: 10.1177/0333102420960039] [Reference Citation Analysis]
44 Ekstein D, Schachter SC. Postictal headache. Epilepsy Behav 2010;19:151-5. [PMID: 20829119 DOI: 10.1016/j.yebeh.2010.06.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
45 Schwedt TJ, Silberstein SD. 14th International Headache Congress: clinical highlights. Headache 2010;50:509-19. [PMID: 20456145 DOI: 10.1111/j.1526-4610.2010.01615.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
46 Lipton RB, Mcginley JS, Shulman KJ, Silberstein SD, Wirth RJ, Buse DC. AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial: Headache. Headache: The Journal of Head and Face Pain 2018;58:229-42. [DOI: 10.1111/head.13199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
47 Peer Mohamed B, Goadsby PJ, Prabhakar P. Safety and efficacy of flunarizine in childhood migraine: 11 years’ experience, with emphasis on its effect in hemiplegic migraine: Flunarizine in Childhood Migraine. Developmental Medicine & Child Neurology 2012;54:274-7. [DOI: 10.1111/j.1469-8749.2011.04154.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
48 Willenberg T, Smith PC, Shepherd A, Davies AH. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review. Phlebology 2013;28:123-31. [PMID: 23761921 DOI: 10.1258/phleb.2012.012051] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
49 Sokolov AY, Lyubashina OA, Sivachenko IB, Berkovich RR, Panteleev SS. Intravenous valproate inhibits ongoing and evoked activity of dura-sensitive thalamic neurons in rats. Eur J Pharmacol 2013;715:204-11. [PMID: 23732564 DOI: 10.1016/j.ejphar.2013.05.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
50 Luo G, Chen L, Conway CM, Denton R, Keavy D, Signor L, Kostich W, Lentz KA, Santone KS, Schartman R, Browning M, Tong G, Houston JG, Dubowchik GM, Macor JE. Discovery of (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): an oral calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraine. J Med Chem 2012;55:10644-51. [PMID: 23153230 DOI: 10.1021/jm3013147] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
51 Martins-Oliveira M, Tavares I, Goadsby PJ. Was it something I ate? Understanding the bidirectional interaction of migraine and appetite neural circuits. Brain Res 2021;1770:147629. [PMID: 34428465 DOI: 10.1016/j.brainres.2021.147629] [Reference Citation Analysis]
52 Purdy RA. Migraine is curable! Neurol Sci 2010;31:141-3. [DOI: 10.1007/s10072-010-0308-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
53 Yarnell E. Herbal Medicine and Migraine. Alternative and Complementary Therapies 2017;23:192-201. [DOI: 10.1089/act.2017.29131.eya] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
54 Pietrobon D. Insights into migraine mechanisms and CaV2.1 calcium channel function from mouse models of familial hemiplegic migraine. J Physiol 2010;588:1871-8. [PMID: 20194127 DOI: 10.1113/jphysiol.2010.188003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
55 Sokolov AY, Lyubashina OA, Amelin AV, Panteleev SS. The role of gamma-aminobutyric acid in migraine pathogenesis. Neurochem J 2014;8:89-102. [DOI: 10.1134/s1819712414020093] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
56 Ong JJY, Wei DY, Goadsby PJ. Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs. Drugs 2018;78:411-37. [PMID: 29396834 DOI: 10.1007/s40265-018-0865-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 12.3] [Reference Citation Analysis]
57 Negro A, Lionetto L, Simmaco M, Martelletti P. CGRP receptor antagonists: an expanding drug class for acute migraine? Expert Opinion on Investigational Drugs 2012;21:807-18. [DOI: 10.1517/13543784.2012.681044] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
58 Buzzi MG, Tassorelli C. Experimental models of migraine. Handb Clin Neurol 2010;97:109-23. [PMID: 20816414 DOI: 10.1016/S0072-9752(10)97008-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
59 Marin JC, Goadsby PJ. Glutamatergic fine tuning with ADX-10059: a novel therapeutic approach for migraine? Expert Opinion on Investigational Drugs 2010;19:555-61. [DOI: 10.1517/13543781003691832] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
60 Scholten-Peeters GGM, Coppieters MW, Durge TSC, Castien RF. Fluctuations in local and widespread mechanical sensitivity throughout the migraine cycle: a prospective longitudinal study. J Headache Pain 2020;21:16. [PMID: 32059650 DOI: 10.1186/s10194-020-1083-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
61 Bhaskar S, Saeidi K, Borhani P, Amiri H. Recent progress in migraine pathophysiology: role of cortical spreading depression and magnetic resonance imaging. Eur J Neurosci 2013;38:3540-51. [PMID: 24118449 DOI: 10.1111/ejn.12368] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
62 Shevel E. The Extracranial Vascular Theory of Migraine-A Great Story Confirmed by the Facts: March 2011. Headache: The Journal of Head and Face Pain 2011;51:409-17. [DOI: 10.1111/j.1526-4610.2011.01844.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
63 Akerman S, Goadsby PJ. Neuronal PAC 1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine. Sci Transl Med 2015;7:308ra157-308ra157. [DOI: 10.1126/scitranslmed.aaa7557] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 10.6] [Reference Citation Analysis]
64 Menon S, Nasir B, Avgan N, Ghassabian S, Oliver C, Lea R, Smith M, Griffiths L. The effect of 1 mg folic acid supplementation on clinical outcomes in female migraine with aura patients. J Headache Pain 2016;17:60. [PMID: 27339806 DOI: 10.1186/s10194-016-0652-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
65 Sarrouilhe D, Dejean C, Mesnil M. Involvement of gap junction channels in the pathophysiology of migraine with aura. Front Physiol 2014;5:78. [PMID: 24611055 DOI: 10.3389/fphys.2014.00078] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
66 Lyubashina OA, Panteleev SS, Sokolov AY. Inhibitory effect of high-frequency greater occipital nerve electrical stimulation on trigeminovascular nociceptive processing in rats. J Neural Transm (Vienna) 2017;124:171-83. [PMID: 27677650 DOI: 10.1007/s00702-016-1626-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
67 Romero-reyes M, Akerman S. Update on Animal Models of Migraine. Curr Pain Headache Rep 2014;18. [DOI: 10.1007/s11916-014-0462-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
68 Andreou AP, Goadsby PJ. Topiramate in the treatment of migraine: A kainate (glutamate) receptor antagonist within the trigeminothalamic pathway. Cephalalgia 2011;31:1343-58. [DOI: 10.1177/0333102411418259] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
69 Andres-Enguix I, Shang L, Stansfeld PJ, Morahan JM, Sansom MS, Lafrenière RG, Roy B, Griffiths LR, Rouleau GA, Ebers GC, Cader ZM, Tucker SJ. Functional analysis of missense variants in the TRESK (KCNK18) K channel. Sci Rep 2012;2:237. [PMID: 22355750 DOI: 10.1038/srep00237] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
70 Hall B, Squires C, Parker KK. Intracellular Loop 2 Peptides of the Human 5HT1a Receptor are Differential Activators of Gi. Int J Pept 2012;2012:490734. [PMID: 22649462 DOI: 10.1155/2012/490734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
71 Neeb L, Bastian K, Villringer K, Gits HC, Israel H, Reuter U, Fiebach JB. No microstructural white matter alterations in chronic and episodic migraineurs: a case-control diffusion tensor magnetic resonance imaging study. Headache 2015;55:241-51. [PMID: 25644380 DOI: 10.1111/head.12496] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.9] [Reference Citation Analysis]
72 Elliott MB, Oshinsky ML, Amenta PS, Awe OO, Jallo JI. Nociceptive neuropeptide increases and periorbital allodynia in a model of traumatic brain injury. Headache 2012;52:966-84. [PMID: 22568499 DOI: 10.1111/j.1526-4610.2012.02160.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
73 Ni Y, Yang L, Han R, Guo G, Huang S, Weng L, Wang X, Li Z, Huang D, Hu R, Zhou H. Implantable Peripheral Nerve Stimulation for Trigeminal Neuropathic Pain: A Systematic Review and Meta-Analysis. Neuromodulation 2021;24:983-91. [PMID: 34008282 DOI: 10.1111/ner.13421] [Reference Citation Analysis]
74 Will C, Messlinger K, Fischer MJ. Vessel diameter measurements at the medullary brainstem in vivo as an index of trigeminal activity. Brain Research 2016;1632:51-7. [DOI: 10.1016/j.brainres.2015.12.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
75 Gonçalves FM, Luizon MR, Speciali JG, Martins-Oliveira A, Dach F, Tanus-Santos JE. Interaction among nitric oxide (NO)-related genes in migraine susceptibility. Mol Cell Biochem 2012;370:183-9. [PMID: 22865486 DOI: 10.1007/s11010-012-1409-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
76 Guo Z, Liu P, Ren F, Cao YQ. Nonmigraine-associated TRESK K+ channel variant C110R does not increase the excitability of trigeminal ganglion neurons. J Neurophysiol 2014;112:568-79. [PMID: 24805079 DOI: 10.1152/jn.00267.2014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
77 Kisler LB, Weissman-fogel I, Coghill RC, Sprecher E, Yarnitsky D, Granovsky Y. Individualization of Migraine Prevention: A Randomized Controlled Trial of Psychophysical-based Prediction of Duloxetine Efficacy. The Clinical Journal of Pain 2019;35:753-65. [DOI: 10.1097/ajp.0000000000000739] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
78 Tedeschi G, Russo A, Conte F, Salemi F, Tessitore A. The role of BOLD-fMRI in elucidating migraine pathophysiology. Neurol Sci 2013;34 Suppl 1:S47-50. [PMID: 23695045 DOI: 10.1007/s10072-013-1383-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
79 Shevel E. The extracranial vascular theory of migraine: an artificial controversy. J Neural Transm 2011;118:525-30. [DOI: 10.1007/s00702-010-0517-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
80 Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014;94:1099-1142. [PMID: 25287861 DOI: 10.1152/physrev.00034.2013] [Cited by in Crossref: 446] [Cited by in F6Publishing: 411] [Article Influence: 55.8] [Reference Citation Analysis]
81 Wilcox SL, Veggeberg R, Lemme J, Hodkinson DJ, Scrivani S, Burstein R, Becerra L, Borsook D. Increased Functional Activation of Limbic Brain Regions during Negative Emotional Processing in Migraine. Front Hum Neurosci 2016;10:366. [PMID: 27507939 DOI: 10.3389/fnhum.2016.00366] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
82 García-Boll E, Martínez-Lorenzana G, Condés-Lara M, González-Hernández A. Oxytocin inhibits the rat medullary dorsal horn Sp5c/C1 nociceptive transmission through OT but not V1A receptors. Neuropharmacology 2018;129:109-17. [PMID: 29169960 DOI: 10.1016/j.neuropharm.2017.11.031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
83 Giacomozzi ARE, Vindas AP, Junior AADS, Bordini CA, Buonanotte CF, Roesler CADP, Brito CM, Perez C, Carvalho DDS, Macedo DDPD, Piovesan EJ, Sarmento EM, Melhado EM, Éckeli FD, Kowacs F, Sobrino F, Rabello GD, Rada G, Souza JAD, Casanovas JR, Durán JC, Calia LC, Medina LRP, Queiroz LPD, Ciciarelli MC, Valença MM, Cusicanqui M, Jimenez MKV, Goycochea MT, Peres MFP, Sandoval MVF, Vincent MB, Gomes MV, Diez M, Aranaga N, Barrientos N, Kowacs PA, Filho PFM. Latin American consensus on guidelines for chronic migraine treatment. Arq Neuro-Psiquiatr 2013;71:478-86. [DOI: 10.1590/0004-282x20130066] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
84 Wilkins AJ, Haigh SM, Mahroo OA, Plant GT. Photophobia in migraine: A symptom cluster? Cephalalgia 2021;:3331024211014633. [PMID: 33990148 DOI: 10.1177/03331024211014633] [Reference Citation Analysis]
85 Diener HC, Barbanti P, Dahlöf C, Reuter U, Habeck J, Podhorna J. BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study. Cephalalgia 2011;31:573-84. [PMID: 21172952 DOI: 10.1177/0333102410388435] [Cited by in Crossref: 161] [Cited by in F6Publishing: 146] [Article Influence: 13.4] [Reference Citation Analysis]
86 Huang D, Ren L, Qiu CS, Liu P, Peterson J, Yanagawa Y, Cao YQ. Characterization of a mouse model of headache. Pain 2016;157:1744-60. [PMID: 27058678 DOI: 10.1097/j.pain.0000000000000578] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
87 Overath CH, Darabaneanu S, Evers MC, Gerber WD, Graf M, Keller A, Niederberger U, Schäl H, Siniatchkin M, Weisser B. Does an aerobic endurance programme have an influence on information processing in migraineurs? J Headache Pain 2014;15:11. [PMID: 24528557 DOI: 10.1186/1129-2377-15-11] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
88 Tfelt-Hansen PC, Olesen J. The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials. J Headache Pain 2012;13:271-5. [PMID: 22430431 DOI: 10.1007/s10194-012-0428-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
89 Summ O, Holland PR, Akerman S, Goadsby PJ. TRPV1 receptor blockade is ineffective in different in vivo models of migraine. Cephalalgia 2011;31:172-80. [DOI: 10.1177/0333102410375626] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
90 Bullock CM, Kelly S. Calcitonin gene-related peptide receptor antagonists: beyond migraine pain--a possible analgesic strategy for osteoarthritis? Curr Pain Headache Rep 2013;17:375. [PMID: 24068339 DOI: 10.1007/s11916-013-0375-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
91 Moutal A, Eyde N, Telemi E, Park KD, Xie JY, Dodick DW, Porreca F, Khanna R. Efficacy of (S)-Lacosamide in preclinical models of cephalic pain. Pain Rep 2016;1:e565. [PMID: 27917413 DOI: 10.1097/PR9.0000000000000565] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
92 Wang Y, Diao T, Zhao Y, Yu L. The clinical characteristics and audiogram in 103 Meniere's disease patients with and without vestibular migraine. Clin Otolaryngol 2018;43:343-7. [DOI: 10.1111/coa.12946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
93 Aoki KR, Francis J. Updates on the antinociceptive mechanism hypothesis of botulinum toxin A. Parkinsonism & Related Disorders 2011;17:S28-33. [DOI: 10.1016/j.parkreldis.2011.06.013] [Cited by in Crossref: 82] [Cited by in F6Publishing: 68] [Article Influence: 7.5] [Reference Citation Analysis]
94 Tchivileva IE, Ohrbach R, Fillingim RB, Greenspan JD, Maixner W, Slade GD. Temporal change in headache and its contribution to the risk of developing first-onset temporomandibular disorder in the Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) study. Pain 2017;158:120-9. [PMID: 27984525 DOI: 10.1097/j.pain.0000000000000737] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
95 Tringali G, Navarra P. Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis. Peptides 2019;116:16-21. [PMID: 31018157 DOI: 10.1016/j.peptides.2019.04.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
96 Dhillon KS, Singh J, Lyall JS. A new horizon into the pathobiology, etiology and treatment of migraine. Medical Hypotheses 2011;77:147-51. [DOI: 10.1016/j.mehy.2011.03.050] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
97 Chalmer MA, Esserlind AL, Olesen J, Hansen TF. Polygenic risk score: use in migraine research. J Headache Pain 2018;19:29. [PMID: 29623444 DOI: 10.1186/s10194-018-0856-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
98 Peng YH, Chen KF, Kao CH, Chen HJ, Hsia TC, Chen CH, Liao WC. Risk of Migraine in Patients With Asthma: A Nationwide Cohort Study. Medicine (Baltimore) 2016;95:e2911. [PMID: 26945388 DOI: 10.1097/MD.0000000000002911] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
99 Smitherman TA, Kolivas ED, Bailey JR. Panic disorder and migraine: comorbidity, mechanisms, and clinical implications. Headache 2013;53:23-45. [PMID: 23278473 DOI: 10.1111/head.12004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
100 De Agostino R, Federspiel B, Cesnulis E, Sandor PS. High-Cervical Spinal Cord Stimulation for Medically Intractable Chronic Migraine: Neuromodulation in chronic migraine. Neuromodulation: Technology at the Neural Interface 2015;18:289-96. [DOI: 10.1111/ner.12236] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
101 Andreou AP, Oshinsky ML. Animal Models of Migraine. In: Ashina M, Geppetti P, editors. Pathophysiology of Headaches. Cham: Springer International Publishing; 2015. pp. 31-66. [DOI: 10.1007/978-3-319-15621-7_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
102 Sintas C, Fernàndez-castillo N, Vila-pueyo M, Pozo-rosich P, Macaya A, Cormand B. Transcriptomic Changes in Rat Cortex and Brainstem After Cortical Spreading Depression With or Without Pretreatment With Migraine Prophylactic Drugs. The Journal of Pain 2017;18:366-75. [DOI: 10.1016/j.jpain.2016.11.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
103 Csati A, Tajti J, Kuris A, Tuka B, Edvinsson L, Warfvinge K. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion. Neuroscience 2012;202:158-68. [DOI: 10.1016/j.neuroscience.2011.10.055] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
104 Kissoon NR, Cutrer FM. Aura and Other Neurologic Dysfunction in or with Migraine. Headache: The Journal of Head and Face Pain 2017;57:1179-94. [DOI: 10.1111/head.13101] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
105 Al-karagholi MA, Hansen JM, Guo S, Olesen J, Ashina M. Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine. Brain 2019;142:2644-54. [DOI: 10.1093/brain/awz199] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 10.7] [Reference Citation Analysis]
106 Barbanti P, Fofi L, Dall'Armi V, Aurilia C, Egeo G, Vanacore N, Bonassi S. Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial. J Headache Pain 2012;13:407-14. [PMID: 22460943 DOI: 10.1007/s10194-012-0440-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
107 Andreou AP, Leese C, Greco R, Demartini C, Corrie E, Simsek D, Zanaboni A, Koroleva K, Lloyd JO, Lambru G, Doran C, Gafurov O, Seward E, Giniatullin R, Tassorelli C, Davletov B. Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine. Neurotherapeutics 2021;18:556-68. [PMID: 33205382 DOI: 10.1007/s13311-020-00967-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Lyubashina OA, Sokolov AY, Panteleev SS. Vagal afferent modulation of spinal trigeminal neuronal responses to dural electrical stimulation in rats. Neuroscience 2012;222:29-37. [PMID: 22800563 DOI: 10.1016/j.neuroscience.2012.07.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
109 Yang CP, Hsieh ML, Chiang JH, Chang HY, Hsieh VC. Migraine and risk of narcolepsy in children: A nationwide longitudinal study. PLoS One 2017;12:e0189231. [PMID: 29216286 DOI: 10.1371/journal.pone.0189231] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
110 Holland S, Fanning KM, Serrano D, Buse DC, Reed ML, Lipton RB. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: Results from the American Migraine Prevalence and Prevention (AMPP) study. Journal of the Neurological Sciences 2013;326:10-7. [DOI: 10.1016/j.jns.2012.12.020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
111 Gasparini CF, Sutherland HG, Griffiths LR. Studies on the pathophysiology and genetic basis of migraine. Curr Genomics 2013;14:300-15. [PMID: 24403849 DOI: 10.2174/13892029113149990007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
112 Ivanusic JJ, Kwok MM, Jennings EA. Peripheral targets of 5-HT(1D) receptor immunoreactive trigeminal ganglion neurons. Headache 2011;51:744-51. [PMID: 21453326 DOI: 10.1111/j.1526-4610.2011.01862.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
113 Tfelt-Hansen PC. Verisimilitude (or "truthlikeness") as an alternative to pro and cons: migraine and cluster headache mechanisms. J Headache Pain 2010;11:379-89. [PMID: 20607582 DOI: 10.1007/s10194-010-0232-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
114 Sokolov AY, Lyubashina OA, Panteleev SS. The role of serotonin receptors in migraine headaches. Neurochem J 2011;5:92-9. [DOI: 10.1134/s1819712411020085] [Cited by in Crossref: 12] [Article Influence: 1.1] [Reference Citation Analysis]
115 Lapira A. Vestibular migraine treatment and prevention. HNO 2019;67:425-8. [DOI: 10.1007/s00106-019-0661-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
116 Huang D, Li S, Dhaka A, Story GM, Cao YQ. Expression of the transient receptor potential channels TRPV1, TRPA1 and TRPM8 in mouse trigeminal primary afferent neurons innervating the dura. Mol Pain 2012;8:66. [PMID: 22971321 DOI: 10.1186/1744-8069-8-66] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 7.7] [Reference Citation Analysis]
117 Lin X, Yi Z, Zhang X, Liu Q, Cai R, Chen C, Zhang H, Zhao P, Pan P. Retinal nerve fiber layer changes in migraine: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e21680. [PMID: 32872037 DOI: 10.1097/MD.0000000000021680] [Reference Citation Analysis]
118 Sarrouilhe D, Dejean C. [Gap junctional intercellular communication: a new mechanism in pathophysiology of migraine with aura. Therapeutic applications]. Pathol Biol (Paris) 2012;60:392-8. [PMID: 22633071 DOI: 10.1016/j.patbio.2012.04.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Sokolov AY, Lyubashina OA, Sivachenko IB, Panteleev SS. Effects of intravenous metamizole on ongoing and evoked activity of dura-sensitive thalamic neurons in rats. Eur J Pharmacol 2014;731:58-64. [PMID: 24650732 DOI: 10.1016/j.ejphar.2014.03.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
120 Shelukhina I, Mikhailov N, Abushik P, Nurullin L, Nikolsky EE, Giniatullin R. Cholinergic Nociceptive Mechanisms in Rat Meninges and Trigeminal Ganglia: Potential Implications for Migraine Pain. Front Neurol 2017;8:163. [PMID: 28496430 DOI: 10.3389/fneur.2017.00163] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
121 Sampaolo S, Liguori G, Vittoria A, Napolitano F, Lombardi L, Figols J, Melone MAB, Esposito T, Di Iorio G. First study on the peptidergic innervation of the brain superior sagittal sinus in humans. Neuropeptides 2017;65:45-55. [DOI: 10.1016/j.npep.2017.04.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
122 Pellegrino ABW, Davis-Martin RE, Houle TT, Turner DP, Smitherman TA. Perceived triggers of primary headache disorders: A meta-analysis. Cephalalgia 2018;38:1188-98. [PMID: 28825314 DOI: 10.1177/0333102417727535] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 14.4] [Reference Citation Analysis]
123 Aytaç B, Coşkun Ö, Alioğlu B, Durak ZE, Büber S, Tapçi E, Öcal R, İnan LE, Durak İ, Yoldaş TK. Decreased antioxidant status in migraine patients with brain white matter hyperintensities. Neurol Sci 2014;35:1925-9. [DOI: 10.1007/s10072-014-1864-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
124 Chen L, Li X, Huang L, Wu Q, Chen L, Wan Q. Chemical stimulation of the intracranial dura activates NALP3 inflammasome in trigeminal ganglia neurons. Brain Res 2014;1566:1-11. [PMID: 24769167 DOI: 10.1016/j.brainres.2014.04.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
125 Schürks M, Rist PM, Kurth T. 5-HTTLPR polymorphism in the serotonin transporter gene and migraine: a systematic review and meta-analysis. Cephalalgia 2010;30:1296-305. [PMID: 20959425 DOI: 10.1177/0333102410362929] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
126 Schürks M, Rist PM, Zee RY, Chasman DI, Kurth T. Tumour necrosis factor gene polymorphisms and migraine: a systematic review and meta-analysis. Cephalalgia 2011;31:1381-404. [PMID: 22001640 DOI: 10.1177/0333102411419022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
127 Tfelt-Hansen P, Olesen J. Possible site of action of CGRP antagonists in migraine. Cephalalgia 2011;31:748-50. [PMID: 21383046 DOI: 10.1177/0333102411398403] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
128 Ishiyama S, Shibata Y, Ayuzawa S, Matsushita A, Matsumura A. Clinical Effect of C2 Peripheral Nerve Field Stimulation Using Electroacupuncture for Primary Headache. Neuromodulation 2018;21:793-6. [PMID: 29566284 DOI: 10.1111/ner.12772] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
129 Braunitzer G, Rokszin A, Kóbor J, Nagy A, Sztriha L, Benedek G. Development of visual contour integration in children with migraine without aura. Cephalalgia 2011;31:1048-56. [DOI: 10.1177/0333102411410611] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
130 Marciszewski KK, Meylakh N, Di Pietro F, Macefield VG, Macey PM, Henderson LA. Altered brainstem anatomy in migraine. Cephalalgia 2018;38:476-86. [DOI: 10.1177/0333102417694884] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
131 Ambrosini A, Iezzi E, Perrotta A, Kisialiou A, Nardella A, Berardelli A, Pierelli F, Schoenen J. Correlation between habituation of visual-evoked potentials and magnetophosphene thresholds in migraine: A case-control study. Cephalalgia 2016;36:258-64. [DOI: 10.1177/0333102415590241] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
132 Lawley JS, Levine BD, Williams MA, Malm J, Eklund A, Polaner DM, Subudhi AW, Hackett PH, Roach RC. Cerebral spinal fluid dynamics: effect of hypoxia and implications for high-altitude illness. Journal of Applied Physiology 2016;120:251-62. [DOI: 10.1152/japplphysiol.00370.2015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
133 Assaf AT, Hillerup S, Rostgaard J, Puche M, Blessmann M, Kohlmeier C, Pohlenz P, Klatt JC, Heiland M, Caparso A, Papay F. Technical and surgical aspects of the sphenopalatine ganglion (SPG) microstimulator insertion procedure. Int J Oral Maxillofac Surg 2016;45:245-54. [PMID: 26559753 DOI: 10.1016/j.ijom.2015.09.023] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
134 Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci 2011;12:570-84. [DOI: 10.1038/nrn3057] [Cited by in Crossref: 333] [Cited by in F6Publishing: 292] [Article Influence: 30.3] [Reference Citation Analysis]
135 Khan J, Asoom LIA, Sunni AA, Rafique N, Latif R, Saif SA, Almandil NB, Almohazey D, AbdulAzeez S, Borgio JF. Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomed Pharmacother 2021;139:111557. [PMID: 34243621 DOI: 10.1016/j.biopha.2021.111557] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
136 Uchitel OD, Inchauspe CG, Urbano FJ, Di Guilmi MN. CaV2.1 voltage activated calcium channels and synaptic transmission in familial hemiplegic migraine pathogenesis. J Physiol Paris 2012;106:12-22. [PMID: 22074995 DOI: 10.1016/j.jphysparis.2011.10.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
137 Lambru G, Andreou AP, Guglielmetti M, Martelletti P. Emerging drugs for migraine treatment: an update. Expert Opin Emerg Drugs 2018;23:301-18. [PMID: 30484333 DOI: 10.1080/14728214.2018.1552939] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
138 Gazerani P, Au S, Dong X, Kumar U, Arendt-Nielsen L, Cairns BE. Botulinum neurotoxin type A (BoNTA) decreases the mechanical sensitivity of nociceptors and inhibits neurogenic vasodilation in a craniofacial muscle targeted for migraine prophylaxis. Pain 2010;151:606-16. [PMID: 20728992 DOI: 10.1016/j.pain.2010.07.029] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
139 Eftekhari S, Edvinsson L. Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level. BMC Neurosci 2011;12:112. [PMID: 22074408 DOI: 10.1186/1471-2202-12-112] [Cited by in Crossref: 100] [Cited by in F6Publishing: 96] [Article Influence: 9.1] [Reference Citation Analysis]
140 Wulf-Johansson H, Amrutkar DV, Hay-Schmidt A, Poulsen AN, Klaerke DA, Olesen J, Jansen-Olesen I. Localization of large conductance calcium-activated potassium channels and their effect on calcitonin gene-related peptide release in the rat trigemino-neuronal pathway. Neuroscience 2010;167:1091-102. [PMID: 20211697 DOI: 10.1016/j.neuroscience.2010.02.063] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
141 Mykland MS, Bjørk MH, Stjern M, Sand T. Alterations in post-movement beta event related synchronization throughout the migraine cycle: A controlled, longitudinal study. Cephalalgia 2018;38:718-29. [PMID: 28478712 DOI: 10.1177/0333102417709011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
142 Reyngoudt H, Paemeleire K, Descamps B, De Deene Y, Achten E. 31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients. Cephalalgia 2011;31:1243-53. [PMID: 21289000 DOI: 10.1177/0333102410394675] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 4.9] [Reference Citation Analysis]
143 Jansen-Olesen I, Tfelt-Hansen P, Olesen J. Animal migraine models for drug development: status and future perspectives. CNS Drugs 2013;27:1049-68. [PMID: 24234657 DOI: 10.1007/s40263-013-0121-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
144 Tedeschi G, Russo A, Tessitore A. Relevance of functional neuroimaging studies for understanding migraine mechanisms. Expert Rev Neurother 2013;13:275-85. [PMID: 23448217 DOI: 10.1586/ern.13.20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
145 Becker WJ, Chitsantikul P. Too much of a good thing? Brain hyper excitability and migraine. Can J Neurol Sci 2011;38:189-90. [PMID: 21320816 DOI: 10.1017/s031716710001129x] [Reference Citation Analysis]
146 Purdy RA. Closing remarks: what future prospects can we expect in migraine management? Neurol Sci 2013;34:23-6. [DOI: 10.1007/s10072-013-1361-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
147 Jain S, Yuan H, Spare N, Silberstein SD. Erenumab in the treatment of migraine. Pain Management 2018;8:415-26. [DOI: 10.2217/pmt-2018-0037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
148 Abdallah K, Gendron L. The Delta Opioid Receptor in Pain Control. Handb Exp Pharmacol 2018;247:147-77. [PMID: 28510066 DOI: 10.1007/164_2017_32] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
149 Qavi A, Jasrotia RB, Maurya PK, Singh AK, Kulshreshtha D, Ansari A, Thacker AK, Kanchan A. Autonomic Function Tests, Heart Rate Variability, and Electrophysiological Evaluation in Patients With a Primary Episodic Headache: An Observational Study. J Clin Neurophysiol 2022. [PMID: 35512198 DOI: 10.1097/WNP.0000000000000943] [Reference Citation Analysis]
150 Classey J, Bartsch T, Goadsby P. Distribution of 5-HT1B, 5-HT1D and 5-HT1F receptor expression in rat trigeminal and dorsal root ganglia neurons: Relevance to the selective anti-migraine effect of triptans. Brain Research 2010;1361:76-85. [DOI: 10.1016/j.brainres.2010.09.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
151 Meents JE, Hoffmann J, Chaplan SR, Neeb L, Schuh-Hofer S, Wickenden A, Reuter U. Two TRPV1 receptor antagonists are effective in two different experimental models of migraine. J Headache Pain 2015;16:57. [PMID: 26109436 DOI: 10.1186/s10194-015-0539-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
152 Pietrobon D. CaV2.1 channelopathies. Pflugers Arch 2010;460:375-93. [PMID: 20204399 DOI: 10.1007/s00424-010-0802-8] [Cited by in Crossref: 129] [Cited by in F6Publishing: 118] [Article Influence: 10.8] [Reference Citation Analysis]
153 Anttila V, Stefansson H, Kallela M, Todt U, Terwindt GM, Calafato MS, Nyholt DR, Dimas AS, Freilinger T, Müller-Myhsok B. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet. 2010;42:869-873. [PMID: 20802479 DOI: 10.1038/ng.652] [Cited by in Crossref: 264] [Cited by in F6Publishing: 232] [Article Influence: 22.0] [Reference Citation Analysis]
154 Tajti J, Párdutz A, Vámos E, Tuka B, Kuris A, Bohár Z, Fejes A, Toldi J, Vécsei L. Migraine is a neuronal disease. J Neural Transm (Vienna) 2011;118:511-24. [PMID: 21161301 DOI: 10.1007/s00702-010-0515-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
155 Kasteleijn-Nolst Trenité DG, Verrotti A, Di Fonzo A, Cantonetti L, Bruschi R, Chiarelli F, Villa MP, Parisi P. Headache, epilepsy and photosensitivity: how are they connected? J Headache Pain 2010;11:469-76. [PMID: 20963464 DOI: 10.1007/s10194-010-0229-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
156 Jones MG, Andreou AP, McMahon SB, Spanswick D. Pharmacology of reflex blinks in the rat: a novel model for headache research. J Headache Pain 2016;17:96. [PMID: 27770405 DOI: 10.1186/s10194-016-0686-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
157 Borsook D, Aasted CM, Burstein R, Becerra L. Migraine Mistakes: Error Awareness. Neuroscientist 2014;20:291-304. [PMID: 24047609 DOI: 10.1177/1073858413503711] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
158 Ren L, Chang MJ, Zhang Z, Dhaka A, Guo Z, Cao YQ. Quantitative Analysis of Mouse Dural Afferent Neurons Expressing TRPM8, VGLUT3, and NF200. Headache 2018;58:88-101. [PMID: 28925503 DOI: 10.1111/head.13188] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
159 Fonteh AN, Chung R, Sharma TL, Fisher RD, Pogoda JM, Cowan R, Harrington MG. Cerebrospinal fluid phospholipase C activity increases in migraine. Cephalalgia 2011;31:456-62. [PMID: 20937607 DOI: 10.1177/0333102410383589] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
160 Russo A, Tessitore A, Tedeschi G. Migraine and Trigeminal System—I can Feel it Coming…. Curr Pain Headache Rep 2013;17. [DOI: 10.1007/s11916-013-0367-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
161 Akerman S, Holland PR, Hoffmann J. Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception. Cephalalgia 2013;33:577-92. [PMID: 23671254 DOI: 10.1177/0333102412472071] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
162 Sokolov AY, Murzina AA, Osipchuk AV, Lyubashina OA, Amelin AV. Cholinergic mechanisms of headaches. Neurochem J 2017;11:194-212. [DOI: 10.1134/s1819712417020131] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
163 Caprara F, Letícia A, Rissardo JP, Leite MT, Silveira JO, Jauris PG, Arend J, Kegler A, Royes F, Fernando L, Fighera MR. Characteristics of Post-Ictal Headaches in Patients with Epilepsy: a Longitudinal Study. Seizure 2020;81:244-9. [DOI: 10.1016/j.seizure.2020.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Maleki N, Androulakis XM. Is There Any MRI Pattern That Discriminates Female From Male Migraine Patients? Front Neurol 2019;10:961. [PMID: 31551917 DOI: 10.3389/fneur.2019.00961] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
165 Chiarugi A. A Popperian View on Anti‐CGRP Biologics in Migraine. Headache: The Journal of Head and Face Pain 2019;59:1855-60. [DOI: 10.1111/head.13695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
166 Bagnato F, Good J. The Use of Antiepileptics in Migraine Prophylaxis. Headache 2016;56:603-15. [PMID: 26935348 DOI: 10.1111/head.12781] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
167 Charbit AR, Akerman S, Goadsby PJ. Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms. Pain 2011;152:2365-76. [PMID: 21868165 DOI: 10.1016/j.pain.2011.07.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
168 Espinosa-Sanchez JM, Lopez-Escamez JA. New insights into pathophysiology of vestibular migraine. Front Neurol 2015;6:12. [PMID: 25705201 DOI: 10.3389/fneur.2015.00012] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
169 Wang X, Liang J, Liu R, Dong Z, Yu S. The expression of succinate semialdehyde dehydrogenase in the caudal part of the spinal trigeminal nucleus is down-regulated after electrical stimulation of the dura mater surrounding the superior sagittal sinus in conscious rats. Neuroscience 2013;248:145-53. [DOI: 10.1016/j.neuroscience.2013.05.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
170 Parisi P. Who's still afraid of the link between headache and epilepsy? Some reactions to and reflections on the article by Marte Helene Bjørk and co-workers. J Headache Pain 2009;10:327-9. [PMID: 19705058 DOI: 10.1007/s10194-009-0149-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
171 Hodkinson DJ, Wilcox SL, Veggeberg R, Noseda R, Burstein R, Borsook D, Becerra L. Increased Amplitude of Thalamocortical Low-Frequency Oscillations in Patients with Migraine. J Neurosci 2016;36:8026-36. [PMID: 27466345 DOI: 10.1523/JNEUROSCI.1038-16.2016] [Cited by in Crossref: 48] [Cited by in F6Publishing: 21] [Article Influence: 9.6] [Reference Citation Analysis]
172 Cankaya C, Tecellioglu M. Foveal Thickness Alterations in Patients with Migraine. Med Arch 2016;70:123-6. [PMID: 27147787 DOI: 10.5455/medarh.2016.70.123-126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
173 Molnár Z, Taylor JS. Shining a spotlight on headaches. Nat Neurosci 2010;13:150-1. [PMID: 20104207 DOI: 10.1038/nn0210-150] [Reference Citation Analysis]
174 Demartini C, Greco R, Zanaboni AM, Sances G, De Icco R, Borsook D, Tassorelli C. Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back. Progress in Neurobiology 2019;177:15-32. [DOI: 10.1016/j.pneurobio.2019.02.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
175 Parisi P, Kasteleijn-nolst Trenité DG. “Migralepsy”: A call for revision of the definition: GRAY MATTERS. Epilepsia 2010;51:932-3. [DOI: 10.1111/j.1528-1167.2009.02407.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
176 Tfelt-hansen P, Olesen J. Taking the Negative View of Current Migraine Treatments: The Unmet Needs. CNS Drugs 2012;26:375-82. [DOI: 10.2165/11630590-000000000-00000] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
177 Srinivasan V, Pandi-Perumal SR, Spence DW, Moscovitch A, Trakht I, Brown GM, Cardinali DP. Potential use of melatonergic drugs in analgesia: mechanisms of action. Brain Res Bull. 2010;81:362-371. [PMID: 20005925 DOI: 10.1016/j.brainresbull.2009.12.001] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
178 Ren L, Dhaka A, Cao YQ. Function and postnatal changes of dural afferent fibers expressing TRPM8 channels. Mol Pain 2015;11:37. [PMID: 26111800 DOI: 10.1186/s12990-015-0043-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
179 Tfelt-Hansen PC, Koehler PJ. One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010. Headache. 2011;51:752-778. [PMID: 21521208 DOI: 10.1111/j.1526-4610.2011.01892.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
180 Chatchaisak D, Srikiatkhachorn A, Grand SM, Govitrapong P, Chetsawang B. The role of calcitonin gene-related peptide on the increase in transient receptor potential vanilloid-1 levels in trigeminal ganglion and trigeminal nucleus caudalis activation of rat. Journal of Chemical Neuroanatomy 2013;47:50-6. [DOI: 10.1016/j.jchemneu.2012.09.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
181 Gooriah R, Nimeri R, Ahmed F. Evidence-Based Treatments for Adults with Migraine. Pain Res Treat 2015;2015:629382. [PMID: 26839703 DOI: 10.1155/2015/629382] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
182 Láinez MJ, Puche M, Garcia A, Gascón F. Sphenopalatine ganglion stimulation for the treatment of cluster headache. Ther Adv Neurol Disord 2014;7:162-8. [PMID: 24790646 DOI: 10.1177/1756285613510961] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
183 Diener H, Dodick DW, Goadsby PJ, Lipton RB, Olesen J, Silberstein SD. Chronic migraine—classification, characteristics and treatment. Nat Rev Neurol 2012;8:162-71. [DOI: 10.1038/nrneurol.2012.13] [Cited by in Crossref: 100] [Cited by in F6Publishing: 76] [Article Influence: 10.0] [Reference Citation Analysis]
184 Olesen J, Ashina M. Emerging migraine treatments and drug targets. Trends Pharmacol Sci 2011;32:352-9. [PMID: 21459461 DOI: 10.1016/j.tips.2011.02.016] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
185 de Tommaso M, Ambrosini A, Brighina F, Coppola G, Perrotta A, Pierelli F, Sandrini G, Valeriani M, Marinazzo D, Stramaglia S, Schoenen J. Altered processing of sensory stimuli in patients with migraine. Nat Rev Neurol 2014;10:144-55. [PMID: 24535465 DOI: 10.1038/nrneurol.2014.14] [Cited by in Crossref: 159] [Cited by in F6Publishing: 133] [Article Influence: 19.9] [Reference Citation Analysis]
186 Díaz-Insa S, Goadsby PJ, Zanchin G, Fortea J, Falqués M, Vila C. The impact of allodynia on the efficacy of almotriptan when given early in migraine: data from the "Act when mild" study. Int J Neurosci 2011;121:655-61. [PMID: 21777163 DOI: 10.3109/00207454.2011.605191] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
187 DosSantos MF, Holanda-Afonso RC, Lima RL, DaSilva AF, Moura-Neto V. The role of the blood-brain barrier in the development and treatment of migraine and other pain disorders. Front Cell Neurosci 2014;8:302. [PMID: 25339863 DOI: 10.3389/fncel.2014.00302] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
188 Gantenbein AR, Sandor PS, Fritschy J, Turner R, Goadsby PJ, Kaube H. Sensory information processing may be neuroenergetically more demanding in migraine patients. Neuroreport 2013;24:202-5. [PMID: 23381352 DOI: 10.1097/WNR.0b013e32835eba81] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
189 Taylor FR. Nutraceuticals and headache: the biological basis. Headache 2011;51:484-501. [PMID: 21352223 DOI: 10.1111/j.1526-4610.2011.01847.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
190 Gentile G, Borro M, Simmaco M, Missori S, Lala N, Martelletti P. Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy. Expert Opinion on Drug Metabolism & Toxicology 2010;7:39-47. [DOI: 10.1517/17425255.2011.538680] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
191 Artero-Morales M, González-Rodríguez S, Ferrer-Montiel A. TRP Channels as Potential Targets for Sex-Related Differences in Migraine Pain. Front Mol Biosci 2018;5:73. [PMID: 30155469 DOI: 10.3389/fmolb.2018.00073] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
192 Cheng YC, Zeng BY, Hung CM, Su KP, Wu YC, Tu YK, Lin PY, Stubbs B, Carvalho AF, Liang CS, Chen TY, Hsu CW, Brunoni AR, Suen MW, Shiue YL, Tseng PT, Wu MK, Li CT. Effectiveness and acceptability of noninvasive brain and nerve stimulation techniques for migraine prophylaxis: a network meta-analysis of randomized controlled trials. J Headache Pain 2022;23:28. [PMID: 35184742 DOI: 10.1186/s10194-022-01401-3] [Reference Citation Analysis]
193 Davies P. What has imaging taught us about migraine? Maturitas 2011;70:34-6. [DOI: 10.1016/j.maturitas.2011.06.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
194 Maher BH, Lea RA, Follett J, Cox HC, Fernandez F, Esposito T, Gianfrancesco F, Haupt LM, Griffiths LR. Association of a GRIA3 Gene Polymorphism With Migraine in an Australian Case-Control Cohort. Headache: The Journal of Head and Face Pain 2013;53:1245-9. [DOI: 10.1111/head.12151] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
195 Smitherman TA, Walters AB, Maizels M, Penzien DB. The use of antidepressants for headache prophylaxis. CNS Neurosci Ther 2011;17:462-9. [PMID: 21951370 DOI: 10.1111/j.1755-5949.2010.00170.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
196 Rosenthal P, Borsook D, Moulton EA. Oculofacial Pain: Corneal Nerve Damage Leading to Pain Beyond the Eye. Invest Ophthalmol Vis Sci 2016;57:5285-7. [PMID: 27723896 DOI: 10.1167/iovs.16-20557] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
197 Tepper SJ, Caparso A. Sphenopalatine Ganglion (SPG): Stimulation Mechanism, Safety, and Efficacy. Headache 2017;57 Suppl 1:14-28. [PMID: 28387016 DOI: 10.1111/head.13035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
198 Yener AÜ, Yılmaz D. Topographic changes measured by the swept source optical coherence tomography in retinal nerve fiber layer, optic nerve head and macula in children with migraine. Acta Neurol Belg 2020;120:661-8. [PMID: 30895457 DOI: 10.1007/s13760-019-01123-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
199 Di Lorenzo C, Coppola G, Currà A, Grieco G, Santorelli FM, Lepre C, Porretta E, Pascale E, Pierelli F. Cortical response to somatosensory stimulation in medication overuse headache patients is influenced by angiotensin converting enzyme (ACE) I/D genetic polymorphism. Cephalalgia 2012;32:1189-97. [PMID: 23053304 DOI: 10.1177/0333102412461890] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
200 Tfelt-Hansen PC. Does sumatriptan cross the blood-brain barrier in animals and man? J Headache Pain 2010;11:5-12. [PMID: 20012125 DOI: 10.1007/s10194-009-0170-y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
201 Diao T, Han L, Jing Y, Wang Y, Ma X, Yu L, Zhang J, Zheng H, Wang L, Li X, Chen N. The clinical characteristics and anatomical variations in patients with intractable unilateral Meniere's Disease with and without migraine. J Vestib Res 2021. [PMID: 34180440 DOI: 10.3233/VES-190755] [Reference Citation Analysis]
202 Lloyd JO, Chisholm KI, Oehle B, Jones MG, Okine BN, Al-Kaisy A, Lambru G, McMahon SB, Andreou AP. Cortical Mechanisms of Single-Pulse Transcranial Magnetic Stimulation in Migraine. Neurotherapeutics 2020;17:1973-87. [PMID: 32632772 DOI: 10.1007/s13311-020-00879-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
203 Cavestro C, Ferrero M, Mandrino S, Di Tavi M, Rota E. Novelty in Inflammation and Immunomodulation in Migraine. Curr Pharm Des 2019;25:2919-36. [PMID: 31686633 DOI: 10.2174/1381612825666190709204107] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
204 Murdin L, Premachandra P, Davies R. Sensory dysmodulation in vestibular migraine: An Otoacoustic Emission Suppression Study. The Laryngoscope 2010;120:1632-6. [DOI: 10.1002/lary.21013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
205 Dasgupta B, Kozlowski E, Schroeder DR, Torrente JR, Xu C, Pin S, Conway CM, Dubowchik GM, Macor JE, Vrudhula VM. Serendipitous oxidation product of BIBN4096BS: A potent CGRP receptor antagonist. Bioorganic & Medicinal Chemistry Letters 2014;24:2744-8. [DOI: 10.1016/j.bmcl.2014.04.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
206 Kagan R, Kainz V, Burstein R, Noseda R. Hypothalamic and basal ganglia projections to the posterior thalamus: possible role in modulation of migraine headache and photophobia. Neuroscience 2013;248:359-68. [PMID: 23806720 DOI: 10.1016/j.neuroscience.2013.06.014] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
207 Harrington MG, Chekmenev EY, Schepkin V, Fonteh AN, Arakaki X. Sodium MRI in a rat migraine model and a NEURON simulation study support a role for sodium in migraine. Cephalalgia 2011;31:1254-65. [PMID: 21816771 DOI: 10.1177/0333102411408360] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
208 Wang Y, Diao T, Han L, Tao Y, Yu L. Association of Meniere's disease and retinal vascular calibre: a prospective observational study in China. BMJ Open 2018;8:e022069. [PMID: 30282681 DOI: 10.1136/bmjopen-2018-022069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
209 Charbit AR, Akerman S, Goadsby PJ. Dopamine: whatʼs new in migraine?: . Current Opinion in Neurology 2010;23:275-81. [DOI: 10.1097/wco.0b013e3283378d5c] [Cited by in Crossref: 67] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
210 Greco R, Demartini C, Francavilla M, Zanaboni AM, Tassorelli C. Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine. Cells 2021;10:2543. [PMID: 34685523 DOI: 10.3390/cells10102543] [Reference Citation Analysis]
211 Meylakh N, Marciszewski KK, Di Pietro F, Macefield VG, Macey PM, Henderson LA. Deep in the brain: Changes in subcortical function immediately preceding a migraine attack. Hum Brain Mapp 2018;39:2651-63. [PMID: 29498776 DOI: 10.1002/hbm.24030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
212 Martins-Oliveira A, Gonçalves FM, Speciali JG, Fontana V, Izidoro-Toledo TC, Belo VA, Dach F, Tanus-Santos JE. Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine. J Neuroimmunol 2012;252:89-94. [PMID: 22907074 DOI: 10.1016/j.jneuroim.2012.07.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
213 Onderwater GL, Van Dongen RM, Zielman R, Terwindt GM, Ferrari MD. Primary headaches. Cerebrospinal Fluid in Neurologic Disorders. Elsevier; 2018. pp. 267-84. [DOI: 10.1016/b978-0-12-804279-3.00016-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
214 Wulf-johansson H, Hay-schmidt A, Poulsen AN, Klaerke DA, Olesen J, Jansen-olesen I. Expression of BKCa channels and the modulatory β-subunits in the rat and porcine trigeminal ganglion. Brain Research 2009;1292:1-13. [DOI: 10.1016/j.brainres.2009.07.047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
215 Quartu M, Serra MP, Boi M, Poddighe L, Picci C, Demontis R, Del Fiacco M. TRPV1 receptor in the human trigeminal ganglion and spinal nucleus: immunohistochemical localization and comparison with the neuropeptides CGRP and SP. J Anat 2016;229:755-67. [PMID: 27456865 DOI: 10.1111/joa.12529] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
216 Pavlovic JM, Akcali D, Bolay H, Bernstein C, Maleki N. Sex-related influences in migraine. J Neurosci Res 2017;95:587-93. [PMID: 27870430 DOI: 10.1002/jnr.23903] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
217 Láinez MJ, Marti AS. Sphenopalatine ganglion stimulation in cluster headache and other types of headache. Cephalalgia 2016;36:1149-55. [PMID: 27152017 DOI: 10.1177/0333102416644968] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
218 Lionetto L, Negro A, Palmisani S, Gentile G, Fiore MRD, Mercieri M, Simmaco M, Smith T, Al-kaisy A, Arcioni R, Martelletti P. Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opinion on Emerging Drugs 2012;17:393-406. [DOI: 10.1517/14728214.2012.709846] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 5.5] [Reference Citation Analysis]
219 Martelletti P, Jensen RH, Antal A, Arcioni R, Brighina F, de Tommaso M, Franzini A, Fontaine D, Heiland M, Jürgens TP, Leone M, Magis D, Paemeleire K, Palmisani S, Paulus W, May A; European Headache Federation. Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain 2013;14:86. [PMID: 24144382 DOI: 10.1186/1129-2377-14-86] [Cited by in Crossref: 138] [Cited by in F6Publishing: 100] [Article Influence: 15.3] [Reference Citation Analysis]
220 Ho TW, Bigal M. Excellent Tolerability But Relatively Low Initial Clinical Efficacy of Telcagepant in Migraine: A Response: April 2011. Headache: The Journal of Head and Face Pain 2011;51:617-8. [DOI: 10.1111/j.1526-4610.2011.01870.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
221 Messlinger K. The chicken and egg problem: CGRP release due to trigeminal activation or vice versa? Cephalalgia 2021;:3331024211042360. [PMID: 34601945 DOI: 10.1177/03331024211042360] [Reference Citation Analysis]
222 Terrier L, Hadjikhani N, Destrieux C. The trigeminal pathways. J Neurol. [DOI: 10.1007/s00415-022-11002-4] [Reference Citation Analysis]
223 Bonavita V, De Simone R, Ranieri A. Pain cognition in migraine: from basic neurophysiology to a behavioral paradigm. Neurol Sci 2018;39:3-9. [DOI: 10.1007/s10072-018-3335-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
224 Ivanusic JJ, Goulding KE, Kwok MM, Jennings EA. Neurochemical classification and projection targets of CART peptide immunoreactive neurons in sensory and parasympathetic ganglia of the head. Neuropeptides 2012;46:55-60. [PMID: 22005173 DOI: 10.1016/j.npep.2011.09.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
225 Burgos-Vega C, Moy J, Dussor G. Meningeal afferent signaling and the pathophysiology of migraine. Prog Mol Biol Transl Sci. 2015;131:537-564. [PMID: 25744685 DOI: 10.1016/bs.pmbts.2015.01.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
226 Andreou AP, Edvinsson L. Mechanisms of migraine as a chronic evolutive condition. J Headache Pain 2019;20:117. [PMID: 31870279 DOI: 10.1186/s10194-019-1066-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
227 Akerman S, Romero-reyes M, Holland PR. Current and novel insights into the neurophysiology of migraine and its implications for therapeutics. Pharmacology & Therapeutics 2017;172:151-70. [DOI: 10.1016/j.pharmthera.2016.12.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
228 Luo G, Chen L, Conway CM, Denton R, Keavy D, Gulianello M, Huang Y, Kostich W, Lentz KA, Mercer SE, Schartman R, Signor L, Browning M, Macor JE, Dubowchik GM. Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine. ACS Med Chem Lett 2012;3:337-41. [PMID: 24900474 DOI: 10.1021/ml300021s] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
229 Liu YF, Xu H. The Intimate Relationship between Vestibular Migraine and Meniere Disease: A Review of Pathogenesis and Presentation. Behav Neurol 2016;2016:3182735. [PMID: 27651559 DOI: 10.1155/2016/3182735] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
230 Fontaine D, Almairac F, Santucci S, Fernandez C, Dallel R, Pallud J, Lanteri-minet M. Dural and pial pain-sensitive structures in humans: new inputs from awake craniotomies. Brain 2018;141:1040-8. [DOI: 10.1093/brain/awy005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
231 Akerman S, Romero-reyes M. Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine. Expert Review of Neurotherapeutics 2014;13:1041-59. [DOI: 10.1586/14737175.2013.827472] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
232 Sokolov AY, Lyubashina OA, Panteleev SS. Spinal trigeminal neurons demonstrate an increase in responses to dural electrical stimulation in the orofacial formalin test. J Headache Pain 2012;13:75-82. [PMID: 22116533 DOI: 10.1007/s10194-011-0404-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
233 Fontaine D, Almairac F. Pain during awake craniotomy for brain tumor resection. Incidence, causes, consequences and management. Neurochirurgie 2017;63:204-7. [DOI: 10.1016/j.neuchi.2016.08.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
234 Ekici B, Unal-cevik I, Akgul-ercan E, Morkavuk G, Yakut Y, Erkan AF. Duration of Migraine Is Associated with Cardiac Diastolic Dysfunction. Pain Med 2013;14:988-93. [DOI: 10.1111/pme.12105] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
235 Puledda F, Messina R, Goadsby PJ. An update on migraine: current understanding and future directions. J Neurol 2017;264:2031-9. [PMID: 28321564 DOI: 10.1007/s00415-017-8434-y] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 11.2] [Reference Citation Analysis]
236 Sokolov AY, Lyubashina OA, Berkovich RR, Panteleev SS. Intravenous dextromethorphan/quinidine inhibits activity of dura-sensitive spinal trigeminal neurons in rats. Eur J Pain 2015;19:1086-94. [PMID: 25410439 DOI: 10.1002/ejp.631] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
237 Cox HC, Lea RA, Bellis C, Nyholt DR, Dyer TD, Haupt LM, Charlesworth J, Matovinovic E, Blangero J, Griffiths LR. Heritability and genome-wide linkage analysis of migraine in the genetic isolate of Norfolk Island. Gene 2012;494:119-23. [PMID: 22197687 DOI: 10.1016/j.gene.2011.11.056] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
238 Bisdorff AR. Management of vestibular migraine. Ther Adv Neurol Disord 2011;4:183-91. [PMID: 21694818 DOI: 10.1177/1756285611401647] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
239 Ivanusic JJ, Kwok MMK, Ahn AH, Jennings EA. 5-HT(1D) receptor immunoreactivity in the sphenopalatine ganglion: implications for the efficacy of triptans in the treatment of autonomic signs associated with cluster headache. Headache 2011;51:392-402. [PMID: 21352213 DOI: 10.1111/j.1526-4610.2011.01843.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
240 Yang F, Chou K, Kuo C, Lin Y, Lin C, Wang S. The pathophysiology of episodic cluster headache: Insights from recent neuroimaging research. Cephalalgia 2018;38:970-83. [DOI: 10.1177/0333102417716932] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
241 Demircan S, Ataş M, Arık Yüksel S, Ulusoy MD, Yuvacı İ, Arifoğlu HB, Başkan B, Zararsız G. The impact of migraine on posterior ocular structures. J Ophthalmol 2015;2015:868967. [PMID: 25767720 DOI: 10.1155/2015/868967] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
242 Palmirotta R, Ludovici G, Egeo G, Ialongo C, Aurilia C, Fofi L, De Marchis ML, Della-morte D, Barbanti P, Guadagni F. Prion Protein Gene M129V Polymorphism and Variability in Age at Migraine Onset. Headache: The Journal of Head and Face Pain 2013;53:540-5. [DOI: 10.1111/head.12043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]